A
Amirhossein Zabolian
Researcher at Islamic Azad University
Publications - 57
Citations - 2062
Amirhossein Zabolian is an academic researcher from Islamic Azad University. The author has contributed to research in topics: Cancer & microRNA. The author has an hindex of 13, co-authored 45 publications receiving 361 citations.
Papers
More filters
Journal ArticleDOI
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Sepideh Mirzaei,Ali Zarrabi,Farid Hashemi,Amirhossein Zabolian,Hossein Saleki,Adnan Ranjbar,Seyed Hesam Seyed Saleh,Morteza Bagherian,Seyed Omid Sharifzadeh,Kiavash Hushmandi,Alena Liskova,Peter Kubatka,Pooyan Makvandi,Vinay Tergaonkar,Alan Prem Kumar,Milad Ashrafizadeh,Gautam Sethi +16 more
TL;DR: In this paper, it has been shown that microRNAs (miRNAs) can dually inhibit/induce NF-κB signaling thereby affecting the growth and migration of cancer cells.
Journal ArticleDOI
Long non-coding RNAs in the doxorubicin resistance of cancer cells.
Saeed Ashrafizaveh,Milad Ashrafizadeh,Ali Zarrabi,Kiavash Husmandi,Amirhossein Zabolian,Shahinozzaman,Amir Reza Aref,Michael R. Hamblin,Noushin Nabavi,Francesco Crea,Yuzhuo Wang,Kwang Seok Ahn +11 more
Journal ArticleDOI
Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy.
Milad Ashrafizadeh,Masoud Delfi,Farid Hashemi,Amirhossein Zabolian,Hossein Saleki,Morteza Bagherian,Negar Azami,Mahdi Vasheghani Farahani,Seyed Omid Sharifzadeh,Soodeh Hamzehlou,Kiavash Hushmandi,Pooyan Makvandi,Ali Zarrabi,Michael R. Hamblin,Rajender S. Varma +14 more
TL;DR: In this paper, the potential of chitosan-based nanoparticles for the delivery of siRNA in cancer therapy is discussed; proliferation, metastasis and chemoresistance are suppressed by siRNA-loaded CS nanoparticles.
Journal ArticleDOI
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh,Maliheh Entezari,Sepideh Mirzaei,Amirhossein Zabolian,Hossein Saleki,Mohamad Javad Naghdi,Sina J. Sabet,M. Khoshbakht,M. Hashemi,Kiavash Hushmandi,Gautam Sethi,Ali Zarrabi,Alan Prem Kumar,Shing Cheng Tan,N. Papadakis,Athanasios Alexiou,Md. Asiful Islam,Ebrahim Mostafavi,Milad Ashrafizadeh +18 more
TL;DR: The role of exosomes in cancer progression and therapy is discussed in this article , where the authors provide a comprehensive understanding of the role of the exosome in cancer therapy, focusing on their therapeutic value in cancer progress and remodeling of the tumor microenvironment.
Journal ArticleDOI
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh,Sepideh Mirzaei,Mohammad Hossein Gholami,Farid Hashemi,Amirhossein Zabolian,Mehdi Raei,Kiavash Hushmandi,Ali Zarrabi,Nicolas H. Voelcker,Amir Reza Aref,Michael R. Hamblin,Rajender S. Varma,Saeed Samarghandian,I.J. Arostegi,M. Alzola,Alan Prem Kumar,Vijay Kumar Thakur,Noushin Nabavi,Pooyan Makvandi,Franklin R. Tay,Gorka Orive +20 more
TL;DR: Hyaluronic acid-based advanced materials provide a platform for the co-delivery of genes and drugs along with DOX to enhance the efficacy of anti-cancer therapy and overcome chemoresistance.